Silverarc Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 101 |
|
|
2023
Q4 | – | Sell |
-200,000
| Closed | -$11.2M | – | 98 |
|
|
2023
Q3 | $8.71M | Buy |
200,000
+108,787
| +119% | +$3.88M | 3.25% | 9 |
|
|
2023
Q2 | $3.3M | Buy |
+91,213
| New | +$3.76M | 1.11% | 34 |
|
|
2022
Q4 | – | Sell |
-10,220
| Closed | -$714K | – | 110 |
|
|
2022
Q3 | $714K | Sell |
10,220
-26,183
| -72% | -$1.94M | 0.3% | 64 |
|
|
2022
Q2 | $2.44M | Sell |
36,403
-9,719
| -21% | -$618K | 1.15% | 37 |
|
|
2022
Q1 | $3.79K | Sell |
46,122
-14,635
| -24% | -$1.5M | 1.8% | 16 |
|
|
2021
Q4 | $8.91M | Buy |
60,757
+14,816
| +32% | +$2.3M | 3.99% | 7 |
|
|
2021
Q3 | $8.13M | Buy |
45,941
+8,188
| +22% | +$1.32M | 4.71% | 3 |
|
|
2021
Q2 | $6.1K | Buy |
37,753
+32,753
| +655% | +$5.26M | 2.97% | 5 |
|
|
2021
Q1 | $857K | Sell |
5,000
-15,000
| -75% | -$2.97M | 0.48% | 57 |
|
|
2020
Q4 | $4.39M | Buy |
+20,000
| New | +$4.32M | 2.68% | 11 |
|